UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Well Known Stock Indices Worldwide gathers popular indices from different continents. Use this global snapshot to gauge market health.
21,921 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
A bold $1.5 billion investment signals Boston Scientific’s shift into transcatheter aortic valve replacement. Explore...
A surprise move from Berkshire Hathaway signals a broader embrace of technology bets. This article explains why Alpha...
Investors confront a major test coming stock environment as the Fed signals it won’t step in to cushion losses. Morga...
Anthropic is reshaping the AI landscape. This article explains why the company could become a major force in software...
A broad semiconductor ETF beat Nvidia over the past year, reshaping how investors view AI-driven winners and the valu...
Netflix just changed how it reports engagement, and the move could ripple through NFLX stock moves. This guide breaks...
As investors look toward talen (tln) 2025 earnings, the Q4 transcript becomes the compass for revenue, margins, and g...
Investing in small biotech stocks offers the potential for outsized gains — but only with a clear process. This guide...
Electrocore (ECOR) is navigating a pivotal year. This article dives into the 2025 earnings landscape, unpacking reven...
Biotech earnings season shines a spotlight on Delcath Systems. This guide breaks down the 2026 earnings outlook, key ...
Home Depot's Q1 2026 results provide a window into consumer demand, mix shifts, and profitability. This article break...